217 related articles for article (PubMed ID: 22407595)
21. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
22. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
[TBL] [Abstract][Full Text] [Related]
23. Nuclear accumulation of UBC9 contributes to SUMOylation of lamin A/C and nucleophagy in response to DNA damage.
Li Y; Jiang X; Zhang Y; Gao Z; Liu Y; Hu J; Hu X; Li L; Shi J; Gao N
J Exp Clin Cancer Res; 2019 Feb; 38(1):67. PubMed ID: 30744690
[TBL] [Abstract][Full Text] [Related]
24. Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice.
Tsai CL; Liu WL; Hsu FM; Yang PS; Yen RF; Tzen KY; Cheng AL; Chen PJ; Cheng JC
Hepatology; 2018 Feb; 67(2):586-599. PubMed ID: 28646552
[TBL] [Abstract][Full Text] [Related]
25. Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.
Moschos SJ; Jukic DM; Athanassiou C; Bhargava R; Dacic S; Wang X; Kuan SF; Fayewicz SL; Galambos C; Acquafondata M; Dhir R; Becker D
Hum Pathol; 2010 Sep; 41(9):1286-98. PubMed ID: 20561671
[TBL] [Abstract][Full Text] [Related]
26. SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.
Chen AJ; Gao L; Wang XW; Zhao XF; Wang JX
J Virol; 2013 Jan; 87(1):636-47. PubMed ID: 23097446
[TBL] [Abstract][Full Text] [Related]
27. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.
Zhu S; Sachdeva M; Wu F; Lu Z; Mo YY
Oncogene; 2010 Mar; 29(12):1763-72. PubMed ID: 20023705
[TBL] [Abstract][Full Text] [Related]
28. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.
Bentz GL; Whitehurst CB; Pagano JS
J Virol; 2011 Oct; 85(19):10144-53. PubMed ID: 21795333
[TBL] [Abstract][Full Text] [Related]
30. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes.
Tomasi ML; Ramani K; Lopitz-Otsoa F; Rodríguez MS; Li TW; Ko K; Yang H; Bardag-Gorce F; Iglesias-Ara A; Feo F; Pascale MR; Mato JM; Lu SC
Hepatology; 2010 Jun; 51(6):2152-61. PubMed ID: 20196119
[TBL] [Abstract][Full Text] [Related]
31. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
32. UBC9-mediated SUMOylation of Lamin B1 enhances DNA-damage-induced nuclear DNA leakage and autophagy after spinal cord injury.
Fan YP; Lou JS; Jin MR; Zhou CH; Shen HH; Fu CY; Mao XJ; Chen YY; Zhong JJ; Wang LL; Wu JS
J Cell Physiol; 2024 May; 239(5):e31213. PubMed ID: 38308641
[TBL] [Abstract][Full Text] [Related]
33. UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts.
Gupta MK; McLendon PM; Gulick J; James J; Khalili K; Robbins J
Circ Res; 2016 Jun; 118(12):1894-905. PubMed ID: 27142163
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-mediated regulation of Ubc9 expression in cancer cells.
Wu F; Zhu S; Ding Y; Beck WT; Mo YY
Clin Cancer Res; 2009 Mar; 15(5):1550-7. PubMed ID: 19223510
[TBL] [Abstract][Full Text] [Related]
35. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine.
Martínez-Chantar ML; Latasa MU; Varela-Rey M; Lu SC; García-Trevijano ER; Mato JM; Avila MA
J Biol Chem; 2003 May; 278(22):19885-90. PubMed ID: 12660248
[TBL] [Abstract][Full Text] [Related]
36. Ubc9 promotes invasion and metastasis of lung cancer cells.
Li H; Niu H; Peng Y; Wang J; He P
Oncol Rep; 2013 Apr; 29(4):1588-94. PubMed ID: 23381475
[TBL] [Abstract][Full Text] [Related]
37. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells.
Yukita A; Hosoya A; Ito Y; Katagiri T; Asashima M; Nakamura H
Bone; 2012 May; 50(5):1092-9. PubMed ID: 22366399
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.
Agboola AO; Musa AA; Ayoade BA; Banjo AA; Anunobi CC; Deji-Agboola AM; Rakha EA; Nolan C; Ellis IO; Green AR
Pathol Res Pract; 2014 Jan; 210(1):10-7. PubMed ID: 24176171
[TBL] [Abstract][Full Text] [Related]
39. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9.
Deng H; Lin Y; Badin M; Vasilcanu D; Strömberg T; Jernberg-Wiklund H; Sehat B; Larsson O
Biochem Biophys Res Commun; 2011 Jan; 404(2):667-71. PubMed ID: 21147068
[TBL] [Abstract][Full Text] [Related]
40. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
Buschmann T; Lerner D; Lee CG; Ronai Z
J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
